194 related articles for article (PubMed ID: 3872778)
1. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
Traub WH
Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
[TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
3. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
4. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
[TBL] [Abstract][Full Text] [Related]
5. Reliability of in vitro susceptibility tests for detecting coagulase-negative staphylococcal resistance to penicillinase-resistant semisynthetic penicillins.
Lowy FD; Chang DS; Aning V; Williams S; Szilagyi G
J Clin Microbiol; 1983 Nov; 18(5):1122-6. PubMed ID: 6605974
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Waghorn DJ; Azadian BS; Talboys C
Genitourin Med; 1986 Dec; 62(6):373-6. PubMed ID: 2950043
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
Ruczkowska J; Dolna I
Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
[No Abstract] [Full Text] [Related]
8. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
Fuchs PC; Barry AL; Thornsberry C; Gavan TL; Jones RN
Antimicrob Agents Chemother; 1983 Jul; 24(1):31-8. PubMed ID: 6625554
[TBL] [Abstract][Full Text] [Related]
10. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
Holder IA; Vanderpool L; Wesselman J
J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
[No Abstract] [Full Text] [Related]
12. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.
Perryman F; Johnson S; Qadri SM
Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
Corbel MJ; Ibrahim ME; Gill KP
Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
[No Abstract] [Full Text] [Related]
14. The effect of anaerobiosis on antistaphylococcal antibiotics.
Tsukayama DT; Guay DR; Gustilo RB; Wicklund B; Gruninger R; Peterson PK
Orthopedics; 1988 Sep; 11(9):1285-9. PubMed ID: 2971930
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactam susceptibility of coagulase-negative staphylococci causing catheter sepsis in pediatric patients.
Marcon MJ; Nahata MC; Powell DA; Lisby-Sutch SM
Diagn Microbiol Infect Dis; 1990; 13(1):9-15. PubMed ID: 2331855
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
Manian FA; Alford RH
Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
[TBL] [Abstract][Full Text] [Related]
18. Activity of clavulanate-potentiated penicillins against methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Griffin K; Witte W; Svacina W
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():49-54. PubMed ID: 2606819
[TBL] [Abstract][Full Text] [Related]
19. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methods for the interpretation of disk diffusion susceptibility tests for augmentin.
Donnelly JP
Diagn Microbiol Infect Dis; 1986 Sep; 5(3):255-63. PubMed ID: 3757475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
